No Data
No Data
Tianjin Pharmaceutical's Attributable Profit Down 16% in Q2
Tianjin Pharmaceutical Da Ren Tang Confirms Business Validity of Controlling Shareholder's Finance Unit
TJ DaRenTang USD: Financial Statements and Related Announcement-Second Quarter and/ or Half Yearly Results
Tianjin Pharmaceutical Da Ren Tang Repays 350 Million Yuan Temporary Use Funds
Tianjin Pharma Ups Stake in Tianjin Pharmaceutical Group Finance to 30%
TJ DaRenTang USD To Go Ex-Dividend On July 2nd, 2024 With 0.1761 USD Dividend Per Share
No Data